a
Displaying items by tag: Medicare Part D
The Office of the Inspector General found Medicare Part D in 2009 paid $25 million for Schedule II drugs billed as refills, although federal law prohibits refilling these controlled substances.
Published in Pain Management
The Centers for Medicare & Medicaid Services issued a notice to Aetna on April 5 of the agency's intent to impose an intermediate sanction to ensure that Medicare beneficiaries continue to have access to prescription drugs under Medicare's requirements, according to a CMS news release.
Published in News and Analysis

HHS Secretary Kathleen Sebelius has announced $4.3 billion in funding to states to help them offset the cost of Medicare coverage for prescription drugs for state residents eligible for both Medicare and Medicaid, according to an HHS news release.

Published in News and Analysis